168 related articles for article (PubMed ID: 33272174)
1. Bioactive Loaded Lipid-based Nanostructures: A Novel Insight for Age-related Neurodegeneration.
Srivastava R; Choudhury PK; Dev SK; Rathore V
Curr Mol Med; 2021; 21(9):724-794. PubMed ID: 33272174
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases.
Martinelli C; Pucci C; Battaglini M; Marino A; Ciofani G
Adv Healthc Mater; 2020 Feb; 9(3):e1901589. PubMed ID: 31854132
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanocarriers loaded with natural compounds: Potential new therapies for age related neurodegenerative diseases?
Soares TB; Loureiro L; Carvalho A; Oliveira MECDR; Dias A; Sarmento B; Lúcio M
Prog Neurobiol; 2018 Sep; 168():21-41. PubMed ID: 29641983
[TBL] [Abstract][Full Text] [Related]
4. Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases.
Babazadeh A; Mohammadi Vahed F; Jafari SM
J Control Release; 2020 May; 321():211-221. PubMed ID: 32035189
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
[TBL] [Abstract][Full Text] [Related]
6. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
Sharma HS; Sjöquist PO; Ali SF
Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
[TBL] [Abstract][Full Text] [Related]
7. Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions.
Sandhir R; Yadav A; Sunkaria A; Singhal N
Neurochem Int; 2015 Oct; 89():209-26. PubMed ID: 26315960
[TBL] [Abstract][Full Text] [Related]
8. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
9. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
[TBL] [Abstract][Full Text] [Related]
10. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
Babizhayev MA; Kasus-Jacobi A
Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
[TBL] [Abstract][Full Text] [Related]
11. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
Millichap LE; Damiani E; Tiano L; Hargreaves IP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
[TBL] [Abstract][Full Text] [Related]
12. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.
Song J; Lu C; Leszek J; Zhang J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576281
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.
Freeman LR; Keller JN
Biochim Biophys Acta; 2012 May; 1822(5):822-9. PubMed ID: 22206999
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis.
Huguet-Casquero A; Xu Y; Gainza E; Pedraz JL; Beloqui A
Int J Pharm; 2020 Aug; 586():119515. PubMed ID: 32544520
[TBL] [Abstract][Full Text] [Related]
15. Carbon nanostructures: The drug and the delivery system for brain disorders.
Henna TK; Raphey VR; Sankar R; Ameena Shirin VK; Gangadharappa HV; Pramod K
Int J Pharm; 2020 Sep; 587():119701. PubMed ID: 32736018
[TBL] [Abstract][Full Text] [Related]
16. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Patel RJ; Ajazuddin ; Ravichandiran V; Murty US; Alexander A
J Control Release; 2020 May; 321():372-415. PubMed ID: 32061621
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin Mediated Oxidative Stress and Neuroprotective Potential of Antioxidants and AT1 Receptor Blockers.
Prusty SK; Sahu PK; Subudhi BB
Mini Rev Med Chem; 2017; 17(6):518-528. PubMed ID: 27781960
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant therapy in acute central nervous system injury: current state.
Gilgun-Sherki Y; Rosenbaum Z; Melamed E; Offen D
Pharmacol Rev; 2002 Jun; 54(2):271-84. PubMed ID: 12037143
[TBL] [Abstract][Full Text] [Related]
20. Mini-GAGR, an intranasally applied polysaccharide, activates the neuronal Nrf2-mediated antioxidant defense system.
Murphy K; Llewellyn K; Wakser S; Pontasch J; Samanich N; Flemer M; Hensley K; Kim DS; Park J
J Biol Chem; 2018 Nov; 293(47):18242-18269. PubMed ID: 30282635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
